Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Foster City, USA
348 Hatch Drive
Foster City, CA, 94404
USA

People

Founder and CEO

Funding

TOTAL $20.2M
FUNDING TOTAL $20.2M
Series A, 11/2009
Mohr Davidow Ventures
XSeed Capital
$6M
Series B, 8/2011
$4.15M
Venture Round, 4/2012
XSeed Capital
Mohr Davidow Ventures
$4.71M
Venture Round, 7/2012
Mohr Davidow Ventures
XSeed Capital
$328k
Series C, 8/2012
$5.04M

Tags

VitaPath Genetics

VitaPath Genetics is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease. Their first product is a genetic test to identify risk factors that are associated with a common birth defect called Spina Bifida and which can be safely corrected with low-risk vitamin supplementation under the care of a physician.

Recent Milestones

Videos

Screenshots

VitaPath Genetics screenshot
Above: VitaPath Genetics
Uploaded: 11/3/09

Sources

  1. VitaPath Genetics, Inc. Series A $6M (onbiovc.com) [edit]
  2. SEC (sec.gov) [edit]
  3. VC Funding: Q2 2012 source [edit]
  4. VC Funding: Q3 2012 source [edit]
  5. SEC (sec.gov) [edit]
Edit This Page
Last Edited 10/30/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy